Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Canney

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Carboplatin and 5-fluorouracil in advanced and recurrent squamous carcinoma of the head and neckE Junor, P Canney, H Yosef
Cancer Treatment Reviews|July 1, 1997
Developments in radiotherapyP Canney, C Deehan, J Dickson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 18, 2008
Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trialI H Kunkler, P Canney, G van Tienhoven, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Improving adjuvant chemotherapy in breast cancer -- can we get more for less with TACT2?L Johnson, D Cameron, P Barrett-Lee, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 16, 2015
A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer - Anglo Celtic VIIP Canney, E Murray, J Dixon-Hughes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2005
Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapyE De Cock, J Hutton, P Canney, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapyD Bissett, J Paul, G Wishart, et al.
British Journal of Cancer|November 1, 1994
A phase II, multicentre, UK study of vinorelbine in advanced breast cancerC J Twelves, N A Dobbs, A Curnow, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)R E Coleman, L Biganzoli, P Canney, et al.
British Journal of Cancer|February 24, 1998
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancerS A Ridge, J Sludden, X Wei, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Carboplatin and 5-fluorouracil in advanced and recurrent squamous carcinoma of the head and neckE Junor, P Canney, H Yosef
Cancer Treatment Reviews|July 1, 1997
Developments in radiotherapyP Canney, C Deehan, J Dickson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 18, 2008
Elucidating the role of chest wall irradiation in 'intermediate-risk' breast cancer: the MRC/EORTC SUPREMO trialI H Kunkler, P Canney, G van Tienhoven, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|August 21, 2007
Improving adjuvant chemotherapy in breast cancer -- can we get more for less with TACT2?L Johnson, D Cameron, P Barrett-Lee, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 16, 2015
A Prospective Randomised Phase III Clinical Trial Testing the Role of Prophylactic Cranial Radiotherapy in Patients Treated with Trastuzumab for Metastatic Breast Cancer - Anglo Celtic VIIP Canney, E Murray, J Dixon-Hughes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 5, 2005
Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapyE De Cock, J Hutton, P Canney, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1995
Epirubicin chemotherapy and advanced breast cancer after adjuvant CMF chemotherapyD Bissett, J Paul, G Wishart, et al.
British Journal of Cancer|November 1, 1994
A phase II, multicentre, UK study of vinorelbine in advanced breast cancerC J Twelves, N A Dobbs, A Curnow, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)R E Coleman, L Biganzoli, P Canney, et al.
British Journal of Cancer|February 24, 1998
Dihydropyrimidine dehydrogenase pharmacogenetics in patients with colorectal cancerS A Ridge, J Sludden, X Wei, et al.
Pageof 2